Cargando…
Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications
The application of nanotechnology in nuclear medicine offers attractive therapeutic opportunities for the treatment of various diseases, including cancer. Indeed, nanoparticles-conjugated targeted alpha-particle therapy (TAT) would be ideal for localized cell killing due to high linear energy transf...
Autores principales: | Trujillo-Nolasco, Maydelid, Morales-Avila, Enrique, Cruz-Nova, Pedro, Katti, Kattesh V., Ocampo-García, Blanca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398190/ https://www.ncbi.nlm.nih.gov/pubmed/34452084 http://dx.doi.org/10.3390/pharmaceutics13081123 |
Ejemplares similares
-
Development of Nanoradiopharmaceuticals by Labeling Polymer Nanoparticles with Tc-99m
por: Patricio, B. F. de Carvalho, et al.
Publicado: (2013) -
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals
por: Sarcinelli, Michelle Alvares, et al.
Publicado: (2016) -
Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis
por: Khoobchandani, Menka, et al.
Publicado: (2016) -
Toxicity Assessment of [(177)Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes
por: Hernández-Jiménez, Tania, et al.
Publicado: (2022) -
Water-Soluble Chitosan Conjugated DOTA-Bombesin Peptide Capped Gold Nanoparticles as a Targeted Therapeutic Agent for Prostate Cancer
por: Tangthong, Theeranan, et al.
Publicado: (2021)